Hsieh, PhD, a partner and biotechnology analyst with William Blair, and a colleague were similarly positive in a research note: Orforglipron outperformed investor expectations in patients living with both overweight/obesity and type 2 diabetes, which we view as the higher-risk and more difficult-to-treat population. Mini-surge Investors agreed with those upbeat assessments, touching off a mini-surge that sent Lilly shares rising 6% Tuesday, from $695.33 to $736.03
Using retatrutide and tirzepatide together in trials showed improved insulin activity and reduced appetite, helping patients manage Type 2 diabetes
If a patient handles the first four weeks without any nausea, the provider may accelerate the escalation
When to See a Dermatologist for Hair Loss due to Tirzepatide See a dermatologist for hair loss due to Tirzepatide when experiencing noticeable severe symptoms (rapid or excessive shedding, noticeable bald patches, or thinning) that impact their appearance
Older adults may not feel as thirsty and may have less ability to recover